| |
Classification of the PSP |
|
Type of Patient Safety Practice
|
Not Evaluated
|
| |
|
Clinical Risk Management Practice (CRMP)
|
Related practices from PaSQ database
|
| "Best fit" category of the reported practice |
|
Identification of risk and harm
Analysis of risk and harm
There is no specified text here
|
| Topic of the reported practice |
|
Incident reporting and learning system
|
|
Aim and the benefit of the Patient Safety Practice
|
| |
The "ApoCIRS" (CIRS = Critical Incident Reporting Sxstem) is a tool where pharmacists can anonymously report critical incidents affecting patients and customers.
Expert analyse and provide advice.
The outcome (i.e. a short descirption of the circumstances and a recommendation) is visible for all colleagues in the intranet. This way all pharmacists are alert and further incidents which might put patients on risk can be avoided.
|
|
Description of the Patient Safety Practice
|
| |
Desciption of the Workflow:
A Pharmacist happens to make a mistake or nearly made a mistake. After logging in the intranet section of our homepage he anonymously makes a short description of what has happened.
A clearing point gets this information and removes all personal data and identifiability from the text. If additional information is necessary the clearing point can contact the reporter (pharmacist).
Then the facts of the case are forwarded to a committee of experts. They analyse and assess the case and make a recommendation for the best behaviour/reaction in this situation.
The description of the case and the recommendation is visible for all pharmacists in the intranet section.
Thereby, we raise the awareness of all colleagues and hope to avoid similar incidents in the future.
|
| Attachment of relevant written information and/or photos, as appropriate |
There is no specified text here
There is no specified text here
There is no specified text here
There is no specified text here
|
|
Effectiveness of the Patient Safety Practice
|
| |
| Degree of implementation of reported practice |
|
Yes, partly
|
| Level of implementation of reported practice |
|
Unit or ward level
|
| Specific and measurable outcome for the reported practice were defined |
|
Not known
|
| A baseline measurement before implementation of the reported practice was obtained |
|
No
|
| A measurement after full implementation of the reported practice was obtained |
|
No
|
| Evaluation of a "positive" effect of the reported practice on Patient Safety |
|
Effect not known or the intervention has not yet been evaluated
|
| Type of before-and after evaluation |
|
There is no specified text here
|
| Enclosure of a reference or attachment in case of published evaluation's results |
There is no specified text here
There is no specified text here
|
|
Health care context where the Patient Safety Practices was implemented
|
| |
|
Community pharmacy
|
|
Transferability
|
| |
| Successful implementation of this Patient Safety Practice in other health care settings than above stated |
|
Yes
|
| Specification of implementation in another health care setting(s) |
|
Primary care
|
| Successful implementation's level of this Patient Safety Practice across settings |
|
No, not known or not relevant
|
|
Involved health care staff
|
| |
|
Pharmacists
|
|
Patient Involvement
|
| |
| Direct service user's involvement as integral part of this Patient Safety Practice |
|
No
|
| Specification of the service users or their representatives' involvement in the implementation of this Patient Safety Practice |
|
There is no specified text here
|
| Point of time in which service user or their reprasentatives' involvement takes place |
|
There is no specified text here
|
| Active seeking of service users' opinion, feedback, experience, etc. as integral part of this Patient Safety Practice |
|
There is no specified text here
|
| Short description of the service users' level of involvement |
|
There is no specified text here
|
| Public accessibility of information regarding this Patient Safety Practice to patients and citizens/service users |
|
No
|
| List of sources where public information is accessible |
|
There is no specified text here
|
|
Implementation of the Patient Safety Practice
|
| |
| Existing collaboration with other countries or international organisations related to implementation of this Patient Safety Practice |
|
No
|
| Problems encountering in the implememntation course of this Patient Safety Practice like lack of motivation, no management support, etc. |
|
No
|
| List of the most prevelent difficulties encuntered during implementation of this Patient Safety Practice |
|
There is no specified text here
|
| List of the most prevalent drivers for a successful implemetation of this Patient Safety Practice |
|
Motivated staff
|
| Use of any specific incentives to enhance motivation while implementing this Patient Safety Practice |
|
No
|
| Description of used incentives, if any. |
|
There is no specified text here
|
| Existence of support or approval by the clinical or hospital management or any other hihg level authority in the implementation process of this Patient Safety Practice |
|
Yes
|
|
Costs of the Patient Safety Practices
|
| |
| Completion of cost calculation related to this Patient Safety Practice |
|
No
|
| Total number of person days required to implement this Patient Safety Practice |
Clinical staff: There is no specified text here
External consultants: There is no specified text here
Support staff: There is no specified text here
Managerial staff: There is no specified text here
Others: There is no specified text here
Not relevant: There is no specified text here
|
| Total number of person days required for training as preparation for implementation of this Patient Safety Practice |
Clinical staff: There is no specified text here
External consultants: There is no specified text here
Support staff: There is no specified text here
Managerial staff: There is no specified text here
Others: There is no specified text here
Not relevant: There is no specified text here
|
| Total cost in Euro of specific equipment (machines, software, communications supplies, etc.) needed to support implementation of this Patient Safety Practice |
|
There is no specified text here
|
| Associated cost with a work reduction or foregoing in order to deliver this Patient Safety Practice |
|
There is no specified text here
|
|
Contact information
|
| |
Name: Monika Lanz
Country: AUSTRIA
Organisation: Österreichische Apothekerkammer
E-mail: monika.lanz@apotheker.or.at
Phone: There is no specified text here
|
|
|